Ticker: CBRE | Upcoming Earnings: Q2 2026 (Expected late July / early August 2026) | Prepared: July 28, 2026 | Sector ETF Benchmark: IYR (iShares U.S. Real Estate ETF)
Key Takeaway: Setup is constructive but the bar is not low — consensus expects ~$1.48 Adj. EPS for Q2 2026 vs. $1.20 actual a year ago (+23% YoY), and the biggest swing factor is whether infrastructure/data center momentum sustains the pace set in Q1 or shows any deceleration.
CBRE heads into Q2 2026 earnings with strong fundamental momentum but a stock that has given back roughly 12% since the Q1 print, creating a more attractive entry point and a lower bar than the multiple implied at the April highs. Management raised full-year core EPS guidance to $7.60–$7.80 (>20% growth at midpoint) after Q1, with two-thirds of the raise reflecting increased expectations for the remainder of the year — not just Q1 pull-forwards — signaling genuine confidence in the pipeline. Estimate revisions have been modestly positive since the Q1 print, with Q2 consensus Adj. EPS moving from ~$1.51 (as of April 28) to ~$1.48 currently, a slight drift lower that likely reflects macro caution rather than fundamental deterioration. The stock's underperformance vs. the S&P 500 since earnings (CBRE -1.5% vs. SPY +4.6% indexed) appears driven by multiple compression rather than estimate cuts, suggesting sentiment rather than fundamentals is the drag. The key wildcard is the pace of Critical Infrastructure Services revenue within BOE — management guided >60% growth for the full year and Q1 delivered $580M; any sign of project timing slippage or hyperscaler capex caution could pressure the BOE segment and the stock disproportionately, while upside surprise there would likely re-rate the stock sharply.
Key Takeaway: Consensus sets a meaningful but achievable bar — Q2 Adj. EPS of ~$1.48 implies ~23% YoY growth, broadly in line with management’s raised full-year trajectory. Advisory Sales (property sales) is the bigger swing factor given its high operating leverage and the strong but volatile capital markets backdrop.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change (Est. vs. PY) | FY2026 Guidance (Mgmt) | Consensus vs. Guidance |
Total Revenue | $10.53B | $9.72B | $11.24B | +15.6% | $46.8B (FY cons.) | N/A — no quarterly rev. guidance |
Fee Revenue | $6.08B | $5.63B | $6.57B | +16.7% | $27.6B (FY cons.) | N/A — no quarterly fee rev. guidance |
Adjusted EPS — Diluted | $1.61 | $1.20 | $1.48 | +23.3% | $7.60–$7.80 FY2026 | FY cons. $7.72 vs. midpoint $7.70: +0.3% |
Adjusted EBITDA | $831M | $626M | $765M | +22.3% | $3.74B (FY cons.) | N/A — no quarterly EBITDA guidance |
Adj. EBITDA Margin (%) | 7.9% | 6.4% | 6.7% | +30 bps | ~7.9% FY (cons.) | N/A |
Advisory Services Revenue | $2.02B | $1.96B | $2.21B | +12.9% | High-teens SOP growth (FY) | N/A — no quarterly rev. guidance |
BOE Revenue | $6.49B | $5.83B | $6.82B | +17.0% | ~25% SOP growth (FY) | N/A — no quarterly rev. guidance |
Project Management Revenue | $1.84B | $1.72B | $1.93B | +12.5% | Unchanged (FY) | N/A — no quarterly rev. guidance |
Critical Infrastructure (BOE) | $578M | $403M | $646M | +60.3% | >60% growth (FY) | Cons. $646M vs. implied run-rate: on track |
Leasing Revenue | $1.04B | $995M | $1.15B | +15.7% | N/A — no quarterly guidance | N/A |
Advisory Sales (Property Sales) | $513M | $459M | $542M | +18.1% | N/A — no quarterly guidance | N/A |
Source: Visible Alpha Consensus and Actuals Data. All consensus figures as of July 28, 2026. Q1 2026 actuals are the most recently reported figures. Prior year figures are Q2 2025 actuals.
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Adj. EPS | $1.61 | $1.14 | +41.4% | BEAT |
Q1 2026 | Advisory Sales | $513M | $425M | +20.7% | BEAT |
Q4 2025 | Adj. EPS | $2.69 | $2.69 | 0.0% | IN LINE |
Q4 2025 | Advisory Sales | $756M | $731M | +3.4% | BEAT |
Q3 2025 | Adj. EPS | $1.60 | $1.46 | +9.9% | BEAT |
Q3 2025 | Advisory Sales | $545M | $476M | +14.5% | BEAT |
Q2 2025 | Adj. EPS | $1.20 | $1.07 | +12.1% | BEAT |
Q2 2025 | Advisory Sales | $459M | $420M | +9.3% | BEAT |
Q1 2025 | Adj. EPS | $0.89 | $0.76 | +16.5% | BEAT |
Q1 2025 | Advisory Sales | $360M | $376M | -4.3% | MISS |
Q4 2024 | Adj. EPS | $2.28 | $2.23 | +2.2% | BEAT |
Q4 2024 | Advisory Sales | $638M | $612M | +4.2% | BEAT |
Q3 2024 | Adj. EPS | $1.19 | $1.06 | +12.3% | BEAT |
Q3 2024 | Advisory Sales | $420M | $400M | +5.0% | BEAT |
Q2 2024 | Adj. EPS | $0.83 | $0.70 | +18.6% | BEAT |
Q2 2024 | Advisory Sales | $384M | $353M | +8.8% | BEAT |
Pattern: CBRE has beaten Adj. EPS consensus in 7 of the last 8 quarters, with an average beat of ~14% — the Street consistently underestimates earnings power. Advisory Sales beats are also the norm (7 of 8), though Q1 2025 was a miss, suggesting capital markets can be lumpy. The Q1 2026 EPS beat of +41% was an outlier driven by land development pull-forward and infrastructure outperformance.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Management raised FY2026 core EPS guidance at Q1 earnings (April 23) to $7.60–$7.80 from $7.30–$7.60, with tone decidedly more confident — two-thirds of the raise reflects higher expectations for the rest of the year, not just Q1 outperformance. No further formal guidance updates have been issued since the Q1 print; the $1B revolving credit facility (June 23) and $750M senior notes (May 4) are capital structure actions, not guidance changes.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 23) | Revised Guidance | Current Consensus | Note |
FY2026 Core EPS | $7.60–$7.80 (>20% growth at midpoint; raised from $7.30–$7.60) | — | $7.72 | Raised at Q1 earnings; ~2/3 of raise reflects higher H2 expectations. No post-earnings update. |
Advisory SOP Growth (FY2026) | High-teens SOP growth | — | N/A — not tracked separately in VA | Unchanged since Q1 call. Margins at 2019 peak; incremental upside limited. |
BOE SOP Growth (FY2026) | ~25% SOP growth (incl. cost reclassification; high-teens underlying) | — | N/A — not tracked separately in VA | Unchanged. Reclassification is D&A-neutral to net income. Primary margin expansion locus going forward. |
Critical Infrastructure Revenue Growth (FY2026) | >60% growth | — | $2.76B FY cons. (vs. $1.56B in 2025 = +77% implied) | Consensus slightly above guidance midpoint. Key watch item for Q2. |
Project Management SOP (FY2026) | Unchanged from prior guidance | — | $8.35B FY rev. cons. | No change. Mid-teens SOP growth expected; steady and incremental margin gains. |
FCF Conversion (FY2026) | High end of 75–85% target range | — | $1.53B FY cons. | Unchanged. Management expects to end 2026 at high end of conversion target. |
Macro Assumption | No material changes to macro or interest rate environment | — | N/A | Management noted some slowdown in corporate capex decisions (ex-data centers). 10-yr Treasury in 4–4.5% range seen as supportive of capital markets. |
Key Takeaway: Estimates have drifted modestly lower since the Q1 print for Q2 2026 Adj. EPS ($1.51 → $1.48, -2%), while FY2026 estimates have held essentially flat ($7.75 → $7.72, -0.4%) — suggesting the Street is not cutting numbers but is being cautious on near-term seasonality. The gap between FY consensus ($7.72) and guidance midpoint ($7.70) is negligible (+0.3%), indicating estimates are well-anchored to guidance with limited risk of a guidance-driven miss.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (Apr 28, 2026) | Current Consensus (Jul 28, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS — Q2 2026 | $1.51 | $1.48 | -2.0% | No quarterly guidance | No quarterly guidance | N/A | N/A |
Adj. EPS — FY2026 | $7.75 | $7.72 | -0.4% | $7.60–$7.80 | $7.60–$7.80 (unchanged) | 0% | +0.3% vs. $7.70 midpoint |
Total Revenue — Q2 2026 | $11.41B | $11.24B | -1.5% | No quarterly guidance | No quarterly guidance | N/A | N/A |
Total Revenue — FY2026 | $47.19B | $46.83B | -0.8% | No formal FY rev. guidance | No formal FY rev. guidance | N/A | N/A |
Adj. EBITDA — Q2 2026 | $809M | $765M | -5.4% | No quarterly guidance | No quarterly guidance | N/A | N/A |
Adj. EBITDA — FY2026 | $3.85B | $3.74B | -2.9% | No formal FY EBITDA guidance | No formal FY EBITDA guidance | N/A | N/A |
The modest downward drift in Q2 EBITDA estimates (-5.4%) vs. flat EPS estimates (-0.4%) likely reflects the Street modeling a slightly lower margin quarter given the absence of the land development pull-forward that boosted Q1. This is not a red flag — management guided for ~40% of FY EPS in H1, implying Q2 EPS of roughly $1.47–$1.50, consistent with current consensus.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: CBRE has underperformed both the S&P 500 and the IYR real estate ETF since Q1 earnings, declining ~1.5% (indexed) vs. SPY +4.6% and IYR +5.5% — the underperformance appears driven by multiple compression and macro uncertainty rather than estimate cuts, as consensus EPS has barely moved. The stock’s recent recovery from its May trough (~$126) back toward ~$147 suggests the market is beginning to re-engage with the fundamental story ahead of Q2.
CBRE vs. IYR (iShares U.S. Real Estate ETF) vs. S&P 500 (SPY) — Indexed to 100 at Q1 2026 Earnings Date (April 23, 2026). Source: Yahoo Finance / Stock Price Data.
Performance Summary (Apr 23 – Jul 28, 2026): CBRE opened at $149.31 on earnings day and traded as low as ~$125 in late May before recovering to ~$147 by July 28. The S&P 500 gained ~4.6% over the same period while IYR gained ~5.5%, making CBRE a notable laggard despite the strong Q1 beat. Two material events are marked: (1) $750M Senior Notes Offering (May 4) — proceeds used to repay commercial paper, a routine refinancing; and (2) $1B Revolving Credit Facility (June 23) — 364-day senior unsecured facility replacing the prior year’s facility, reinforcing liquidity. Neither event was a catalyst for the stock. The May sell-off appears macro-driven (broader risk-off, real estate sector weakness) rather than CBRE-specific, and the subsequent recovery aligns with improving sentiment into Q2 earnings.
Key Takeaway: Peers reporting in the last 60 days paint a consistently bullish picture for Q2 2026 commercial real estate activity — leasing, capital markets, and data center services are all accelerating, with no signs of demand deceleration. JLL and Cushman & Wakefield both explicitly flagged continued strength into April/Q2, and Marcus & Millichap’s encouraging April results validate the capital markets recovery thesis. CoStar’s Q2 2026 actual results (reported July 28) confirm the CRE data/services environment remains robust.
Note: Only forward-looking commentary about Q2 2026 or the current operating environment is included below. Backward-looking Q1 2025 results commentary has been excluded.
Overall Peer Read-Through Assessment: The peer commentary is uniformly constructive for CBRE’s Q2 2026 print. All three CRE services peers (JLL, CWK, MMI) confirmed continued strength in April/Q2 across leasing, capital markets, and facilities management. CoStar’s actual Q2 results validate the CRE data environment. The only consistent caution is geopolitical uncertainty (Middle East) creating some EMEA/APAC deal delays — a risk CBRE management already flagged on the Q1 call. Data center demand remains unambiguously strong across all peers.
Key Takeaway: The most important development since Q1 earnings is the $750M senior notes offering (May 4) and the $1B revolving credit facility renewal (June 23) — together these signal proactive balance sheet management and ample liquidity heading into what management expects to be a strong H2 2026, with no implications for the earnings print itself.
Key Takeaway: No open-market discretionary buys or sells stand out as a signal — the only open-market sale (CFO Giamartino, May 15) was a 10b5-1 planned sale, and all other transactions are routine director equity awards or tax-withholding dispositions. The absence of discretionary insider selling at current price levels is mildly constructive.
Name | Title | Transaction Type | Shares | Date | Note |
Emma E. Giamartino | CFO & Chief Investment Officer | Open Market Sale (10b5-1) | 2,250 shares | May 15, 2026 | 10b5-1 planned sale; pre-scheduled, not discretionary. Not a signal. |
Chad J. Doellinger | Chief Legal & Admin. Officer | Tax Withholding Disposition (F) | 290 shares | May 1, 2026 | Shares withheld for tax on vesting; obligation-driven, not discretionary. |
Chad J. Doellinger | Chief Legal & Admin. Officer | Open Market Sale (10b5-1) | 107 shares | May 5, 2026 | 10b5-1 planned sale; pre-scheduled, not discretionary. |
Andrew S. Horn | Deputy CFO | Tax Withholding Disposition (F) | 58 shares | May 1, 2026 | Shares withheld for tax on vesting; obligation-driven, not discretionary. |
Brandon B. Boze | Director | Equity Award (A) | 2,746 shares | May 21, 2026 | Routine annual director equity grant; not a market signal. |
Beth F. Cobert | Director | Equity Award (A) | 1,907 shares | May 21, 2026 | Routine annual director equity grant. |
Beth F. Cobert | Director | Gift/Transfer (G) | 2,068 shares | May 27, 2026 | Disposition via gift; not an open-market sale. |
Reginald H. Gilyard | Director | Equity Award (A) | 1,907 shares | May 21, 2026 | Routine annual director equity grant. |
Shira Goodman | Director | Equity Award (A) | 1,907 shares | May 21, 2026 | Routine annual director equity grant. |
Gerardo I. Lopez | Director | Equity Award (A) | 1,907 shares | May 21, 2026 | Routine annual director equity grant. |
Guy A. Metcalfe | Director | Equity Award (A) | 1,907 shares | May 21, 2026 | Routine annual director equity grant. |
Sanjiv Yajnik | Director | Equity Award (A) | 3,433 shares | May 21, 2026 | Routine annual director equity grant. |
Gunjan Soni | Director | Equity Award (A) | 1,907 shares | May 21, 2026 | Routine annual director equity grant. |
Source: Insider Transaction Data (SEC Form 4 filings). Open-market buys and sells only (codes P/S) plus 10b5-1 plan disclosures and tax-withholding dispositions (code F). All transactions since Q1 2026 earnings (April 23, 2026).
Assessment: No discretionary open-market purchases or sales by senior executives. The CFO’s 10b5-1 sale (2,250 shares, ~$330K at ~$147/share) is pre-scheduled and not a signal. All other transactions are routine director equity grants or tax-withholding dispositions. The complete absence of discretionary insider selling at current price levels (~$147, well below the 52-week high) is mildly constructive — insiders are not rushing to sell into any strength.